Compare Edwards Lifesciences Corporation Common Stock (EW) vs MakeMyTrip Ltd (MMYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs MakeMyTrip Ltd — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B), while MakeMyTrip Ltd trades at $42.6 (market cap $4.09B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 11.9× MakeMyTrip Ltd's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, MakeMyTrip Ltd nearer its low. Which is the better fit depends on your goals.
| EW | MMYT | |
|---|---|---|
Market Cap | $48.56B | $4.09B |
Volume | 6,520,488 | 1,828,010 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $94.43 |
52-Week Low | $72.65 | $36.30 |
Enterprise Value | $45.01B | $4.75B |
Typical Hold Time | — | 12 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MakeMyTrip (MMYT) trades at $43.41 with minimal daily movement (+0.09%). The stock shows mixed technical signals with a bearish overall trend but oversold RSI readings. Fundamentally, the company maintains strong revenue growth (2025: $978M, 2026: $1.1B) and a robust gross margin of 73.45%, though net margins have compressed from 9.72% to 3.22%. Recent earnings show volatility with one beat and two misses in the last four quarters.
Wall Street maintains strong bullish sentiment with a $77 consensus price target (72.7% buy ratings), representing 77% upside potential. Key risks include declining profitability margins, significant debt increase forecasted for 2026, and competitive pressures in the travel sector. The planned Indian subsidiary IPO could unlock value but execution remains critical.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →
